Database

Startups

Main Industry
Health Care
Main Product/Service
ArteVu is a revolutionary medical-grade blood pressure monitoring device featuring non-invasive, continuous monitoring technology. It updates blood pressure and heart rate data every 2 seconds and displays arterial pressure waveforms in real time, continuously tracking patients’ dynamic changes. Using patented semiconductor sensors and proprietary algorithms, ArteVu has been clinically validated in medical centers, achieving an average error of less than 5 mmHg compared to arterial catheters, meeting ISO standards and providing near-catheter-level accuracy.
The content above was translated by Ai
Founded Year
2021
Unified Business No.
83248817
Status
Active
Number of Employees
20
Total Paid-in Capital
- (NT$)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups. Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed. Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
About the Company
CARDIO RING TECNNOLOGIES is a startup founded by a multidisciplinary team of experts, with a mission to advance cardiovascular health by transforming how blood pressure is measured. Current invasive arterial catheters and intermittent cuff measurements are not ideal for patients, so CARDIO RING TECNNOLOGIES is developing the best continuous, non-invasive blood pressure monitoring technology to help protect lives, making blood pressure measurement simpler, more convenient, and accessible anytime, anywhere.

The content above was translated by Ai
more ↓

Similar Companies

tst biomedical electronics Co., Ltd.

1. iProtin® Surface Acoustic Wave (SAW) Core Technology Platform: iProtin® is a next-generation in vitro diagnostic (IVD) solution developed by tst biomedical electronics Co., Ltd. Utilizing high-frequency reflective shear-horizontal surface acoustic wave (SH-SAW) sensor chips, it can detect real-time changes in mass and viscoelasticity on the sensing surface during antigen-antibody binding. This allows for highly sensitive quantitative or semi-quantitative detection results without the need for enzyme or fluorescent labeling. Benefiting from the unique physical properties of surface acoustic wave technology, the detection process is free from interference by blood cells, allowing the direct use of a 5 μL fingertip whole blood sample to complete high-sensitivity analysis within 3 minutes. This platform technology has obtained patents in multiple countries, features high scalability and a modular design, and can be flexibly applied to the detection of various disease biomarkers, including cardiovascular diseases, inflammatory markers, and cancer-related proteins.

2. Support for Customized Development and OEM/ODM Collaboration Models: tst biomedical electronics Co., Ltd. provides one-stop manufacturing services ranging from wafer fabrication to diagnostic biochips, assisting customers in rapidly achieving commercialization. We possess patented cavity packaging technology, which can effectively protect the surface acoustic wave sensor chip and enhance signal stability and reliability; paired with 10 nL high-precision biomaterial coating technology, it can effectively reduce production costs and facilitate biochip miniaturization. tst biomedical electronics Co., Ltd. supports customized development and OEM/ODM collaboration models, and can design chips, packaging modules, and biocoating solutions according to specific requirements, assisting academic and research institutions, startups, or corporate clients in smoothly transitioning from proof of concept and trial production to mass production.

3. The iProtin® testing platform provides API integration capabilities, which can integrate personal health indices, lifestyle habits, and medication records to achieve companion diagnostics and personalized health management. Through connections with wearable devices, health cloud platforms, or electronic medical record (EMR) systems, users can adjust exercise intensity, dietary intake, or medication dosage in real time based on test results, visualizing health data and truly implementing proactive and precise health management.
回頁面最頂端